Advanced Search

 

Study ID Status Title Patient Level Data
113572 Completed Immunogenicity and safety of GSK Biologicals’ pandemic influenza candidate vaccine GSK2340272A Study Listed on ClinicalStudyDataRequest.com
113574 Completed Safety and Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2340272A in Adults Aged 18 to 60 Years Study Listed on ClinicalStudyDataRequest.com
113581 Completed A Phase I, Randomized, Single-Blind, Placebo-Controlled Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Food Effect Following Single Oral Doses of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
113583 Completed An Open-Label, Multi-Center Study to Investigate the Objective Response Rate, Safety, and Pharmacokinetics of GSK1120212, a MEK Inhibitor, in BRAF Mutation-positive Melanoma Subjects Previously Treated with or without a BRAF Inhibitor
113585 Completed Post-Authorization Safety Study (PASS) of GlaxoSmithKline Biologicals’ pandemic influenza vaccine (GSK2340272A) in the United Kingdom (UK)
113586 Completed A phase IV (not interventional), open-label, multicentre study to evaluate the reactogenicity and safety of co-administration of GlaxoSmithKline Biologicals’ DTPa (Infanrix) and IPV (Poliorix) vaccines administered as three-dose primary immunisation course at 3, 4.5 and 6 months of age in healthy children in Russian Federation
113589 Completed A randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of GSK573719 delivered once-daily over 28 days in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
113596 Completed An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of Avamys® administered in Korean patients according to the prescribing information
113615 Completed Feasibility study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine in healthy infants at 2, 4 and 12 months of age Study Listed on ClinicalStudyDataRequest.com
113625 Completed A Randomized, Placebo Controlled, 3-Way Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo 10mg Administered Twice Daily for 5 Days by a Rotahaler Compared to the Diskhaler in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
113629 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 8 to 12 weeks Study Listed on ClinicalStudyDataRequest.com
113630 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 years and above Study Listed on ClinicalStudyDataRequest.com
113633 Completed A Phase IIB, Randomized, Blinded, Dose-ranging, Active-controlled, Parallel-group, Multi-center study to Evaluate the Dose Response Relationship of GSK1278863 over the first 4 weeks of Treatment and Evaluate the Safety and Efficacy of GSK1278863 over 24 weeks in Hemodialysis-Dependent Subjects with Anemia associated with Chronic Kidney Disease who Switch from Recombinant Human Erythropoietin
113634 Completed Open Label Study to Assess the Pharmacokinetics of GSK1278863A Coadministered with a High Fat Meal or an Inhibitor of CYP2C8 (gemfibrozil) Study Listed on ClinicalStudyDataRequest.com
113635 Completed A Two-part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a High, Single Oral Dose of GSK1278863 (Part A), and a Randomized, Single-blind, Placebo- and Positive-controlled, Four-way Crossover Study to Assess the Effect of Single, Oral Dose of GSK1278863 on Cardiac Repolarization (Part B) in Healthy Volunteers
113637 Completed Observational study to monitor the introduction of flixotide evohaler in the United Kingdom
113638 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
113639 Completed PEM study on Avandia use
113642 Completed Seretide Evohaler PEM study
113642_1 Completed Seretide Evohaler PEM study
113652 Completed Evaluate (post approval) the adherence to the prescribing information for ARIXTRA® (fondaparinux) in ACS patients- commitment of the fondaparinux EU-RMP
113655 Completed Paroxetine (Paxil®) in relation to birth defects (Slone)
113656 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_1 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_2 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.